Skip to main content
  • Management
      |Management
    • Compensation
    • Economics
    • Leadership
    • Legal News
    • Mergers & Acquisitions
    • Patient Care
    • Policy & Regulations
    • Practice Management
    • Professional Associations
    • Quality
    • Staffing
  • Imaging
      |Imaging
    • CT
    • MRI
    • Nuclear Medicine
    • Ultrasound
    • Women's Imaging
    • X-ray
  • Technology
      |Technology
    • Artificial Intelligence
    • Enterprise Imaging
    • Imaging Informatics
    • Informatics
    • PACS
  • Videos
  • Conferences
      |Conferences
    • ACR
    • AHRA
    • ARRS
    • ASRT
    • RBMA
    • RSNA
    • SBI
    • SIIM
    • SIR
    • SNMMI
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2025
    • Class of 2024

Search form

Home

Breaking News: GE Healthcare IPO in 2019 ‘unlikely’ after $21.4B deal with Danaher

News You Need to Know Today
Breaking News: GE Healthcare IPO in 2019 ‘unlikely’ after $21.4B deal with Danaher
Monday, February 25, 2019
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Breaking News

GE Healthcare IPO in 2019 ‘unlikely’ after $21.4B deal with Danaher

General Electric (GE) announced on Monday, Feb. 25, that it has entered into a definitive agreement to sell its biopharma business to Danaher Corporation for $21.4 billion. This could significantly impact the company’s plans for an initial public offering (IPO) for GE Healthcare.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

GE Healthcare IPO in 2019 ‘unlikely’ after $21.4B deal with Danaher

Share on Twitter Share on Facebook Share on Linkedin
General Electric (GE) announced on Monday, Feb. 25, that it has entered into a definitive agreement to sell its biopharma business to Danaher Corporation for $21.4 billion. This could significantly impact the company’s plans for an initial public offering (IPO) for GE Healthcare.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Top 10 most popular radiology video interviews this past month
Reducing LDCT false positives | Baseline findings predict long-term cancer risk | Contaminated contrast sickens 10 | More
Research hints at whether LLMs are ready for clinical deployment | Ultrasound finding may signal invasive cancer | More
Radiologists' growing MIPS frustration | Why departments cancel imaging orders | Consolidation influences ACR accreditation
Robot sonographer | AI nearly halves LDCT false positive rates | Hospital system implements radiology AI across entire network
Medicare IR change will 'kill seniors,' pols warn | NPP reads result in more repeat imaging | Referrers refuse to use IR service
Reducing unnecessary breast biopsy referrals | First in-human 4D mammo trial | AI predicts short-term breast cancer risk| More

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …47
    • Page 48
    • Page 49
    • Page 50
    • Current page 51
    • Page 52
    • Page 53
    • Page 54
    • Page 55 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme